EUVIMEDObjevte EUVIMED
BeobachtungsstudieMultizentrische Studie

Racial and Ethnic Disparities in Access to Advanced Therapies for Atopic Dermatitis in the United States

Katrina Abuabara, Christopher G Bunick, Lara Wine Lee, Ayman Grada, Brian Calimlim, Andrea Gelabert Mora, Jeffrey Cizenski, Brenda Simpson, Chibuzo Obi, Rachel Goldberg, Keith D Knapp, Breda Munoz and 3 more

Journal of Drugs in Dermatology · 2026

DOI: 10.36849/jdd.9506 ↗

At a glance

Beobachtungsstudie in Journal of Drugs in Dermatology, 2026. Written by Katrina Abuabara and 14 co-authors. Major MEDLINE topics: Dermatitis, Atopic, Health Services Accessibility, Healthcare Disparities. Cited 1 times so far (Crossref).

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

BACKGROUND: Atopic dermatitis (AD) disproportionately affects diverse patient populations, and complex factors influence access to treatment among different racial and ethnic groups. OBJECTIVE: This study aimed to assess racial and ethnic differences in AD severity and access to treatment in clinical practice. METHODS: The study included patients aged 6 and older with AD enrolled in TARGET-DERM AD, an observational, longitudinal study utilizing electronic medical records from 43 academic and community centers across the United States. RESULTS: The analysis included 1,928 participants: 577 children (30%) and 1,351 adults (70%), with 42% identifying as Non-White. Non-Hispanic (NH) Asian participants exhibited the highest percentage of moderate-to-severe AD at 63%, followed by NH-Black (61%), Hispanic (49%), and NH-White (48%) participants. Over half (56%) of NH-Asian patients reported comorbid asthma. NH-Black and Hispanic individuals were less likely to receive advanced systemic therapies compared to NH-White individuals, with odds ratios of 0.71 and 0.66, respectively, both statistically significant (P

Subjects

MeSH terms (MEDLINE)

Dermatitis, AtopicHealth Services AccessibilityHealthcare DisparitiesAdolescentAdultAgedChildFemaleHumansMaleMiddle AgedYoung AdultHispanic or LatinoLongitudinal StudiesSeverity of Illness IndexUnited StatesWhiteAsianBlack or African American

Cite

APA

Abuabara, K., Bunick, C. G., Lee, L. W., Grada, A., Calimlim, B., Mora, A. G., Cizenski, J., Simpson, B., Obi, C., Goldberg, R., Knapp, K. D., Munoz, B., Perez, A. D., Crawford, J. M., & Silverberg, J. I. (2026). Racial and Ethnic Disparities in Access to Advanced Therapies for Atopic Dermatitis in the United States. Journal of Drugs in Dermatology. https://doi.org/10.36849/jdd.9506

Vancouver

Abuabara K, Bunick CG, Lee LW, Grada A, Calimlim B, Mora AG, et al. Racial and Ethnic Disparities in Access to Advanced Therapies for Atopic Dermatitis in the United States. Journal of Drugs in Dermatology. 2026. doi:10.36849/jdd.9506

BibTeX
@article{Abuabara2026,
  author = {Abuabara, Katrina and Bunick, Christopher G and Lee, Lara Wine and Grada, Ayman and Calimlim, Brian and Mora, Andrea Gelabert and Cizenski, Jeffrey and Simpson, Brenda and Obi, Chibuzo and Goldberg, Rachel and Knapp, Keith D and Munoz, Breda and Perez, Anthony D and Crawford, Julie M and Silverberg, Jonathan I},
  title = {Racial and Ethnic Disparities in Access to Advanced Therapies for Atopic Dermatitis in the United States},
  journal = {Journal of Drugs in Dermatology},
  year = {2026},
  doi = {10.36849/jdd.9506}
}
Start for free →